Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
News Release
CEI: Court Decision against Weed Killer Based on Bad Evidence Could Raise Food Prices, Harm the Environment
Last week, a jury in California awarded $289 million to a former school groundskeeper who claimed glyphosate, an ingredient in the weed killer Roundup, caused…
Blog
End Union Medicaid Dues Skim
Every Medicaid dollar is statutorily required to directly fund care for the elderly or disabled. This requirement is known as the “direct payment requirement.” Congress,…
Blog
Protect Home Healthcare Providers: End Dues Skimming
Our friends at the State Policy Network have produced a compelling new video about the plight of men and women who have been forced…
SCPR
AUDIO: Marc Scribner Discusses Driverless Cars and State Safety Regulations on AirTalk
CEI Senior Fellow Marc Scribner joined AirTalk on Southern California Public Radio to discuss driverless car technology and state safety regulations.
The Washington Examiner
Trump Keeps His Promise, Dying Patients Get a Second Chance At Life
The Washington Examiner cited the Competitive Enterprise Institute on the direct toll to human life that regulations impose as a result of ever-increasing FDA clinical…
The Hill
‘Right to Try’ Is a Win for Patient Rights and President Trump
The Hill cited the Competitive Enterprise Institute on the overwhelming cost of compliance which taxes the American economy and in this case limits pharmaceutical ingenuity…